|
|
||||||||
MICROBIAL PATHOGENICITY |

Research Institute, Departments of Structural Biology and Biochemistry, *Developmental Biology and
Animal Laboratory Services, Hospital for Sick Children, Toronto, Ontario, Canada
Corresponding author: Dr J. Forstner (email: jfforst{at}sickkids.on.ca).
Received 9 Jan. 2000; accepted 2 March 2000.
Abstract
The Burkholderia cepacia complex consists of at least five well-documented bacterial genomovars, each of which has been isolated from the sputum of different patients with cystic fibrosis (CF). Although the world-wide prevalence of this opportunist pathogen in CF patients is low (13%), epidemic clusters occur in geographically isolated regions. Prevalence in some of these clusters is as high as 3040%. The majority of CF B. cepacia isolates belong to genomovar III, but the relationship between genomovar and virulence has not yet been defined. Because the initial stage of infection involves bacterial binding to host tissues, the present study investigated differences in the binding of representative isolates of all five genomovars to fixed nasal sections of UNC cftr (-/-) and (+/+) mice and to human lung explants, biopsy and autopsy tissue of CF and non-CF patients. Binding was highest for isolates of genomovar III, subgroup RAPD type 2, but only if the isolates expressed the cable pili phenotype. Antibodies to the 22-kDa adhesin of cable pili virtually abolished binding. Binding occurred only to cftr (-/-) nasal sections or to CF lung sections and was negligible in cftr (+/+) or human non-CF, histologically normal lung sections. Unlike normal epithelia, the hyperplastic epithelia of CF bronchioles were enriched in cytokeratin 13, a 55-kDa protein that has previously been shown to act as a receptor in vitro for cable-piliated B. cepacia. These findings may help to explain the high transmissibility of Cbl-positive, genomovar III strains of B. cepacia among CF patients.
This article has been cited by other articles:
![]() |
A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF] |
||||
![]() |
P. W. Whitby, T. M. VanWagoner, A. A. Taylor, T. W. Seale, D. J. Morton, J. J. LiPuma, and T. L. Stull Identification of an RTX determinant of Burkholderia cenocepacia J2315 by subtractive hybridization J. Med. Microbiol., January 1, 2006; 55(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Urban, J. B. Goldberg, J. F. Forstner, and U. S. Sajjan Cable Pili and the 22-Kilodalton Adhesin Are Required for Burkholderia cenocepacia Binding to and Transmigration across the Squamous Epithelium Infect. Immun., September 1, 2005; 73(9): 5426 - 5437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Engledow, E. G. Medrano, E. Mahenthiralingam, J. J. LiPuma, and C. F. Gonzalez Involvement of a Plasmid-Encoded Type IV Secretion System in the Plant Tissue Watersoaking Phenotype of Burkholderia cenocepacia J. Bacteriol., September 15, 2004; 186(18): 6015 - 6024. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sajjan, S. Keshavjee, and J. Forstner Responses of Well-Differentiated Airway Epithelial Cell Cultures from Healthy Donors and Patients with Cystic Fibrosis to Burkholderia cenocepacia Infection Infect. Immun., July 1, 2004; 72(7): 4188 - 4199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Cunha, S. A. Sousa, J. H. Leitao, L. M. Moreira, P. A. Videira, and I. Sa-Correia Studies on the Involvement of the Exopolysaccharide Produced by Cystic Fibrosis-Associated Isolates of the Burkholderia cepacia Complex in Biofilm Formation and in Persistence of Respiratory Infections J. Clin. Microbiol., July 1, 2004; 42(7): 3052 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A De Soyza, K Morris, A McDowell, C Doherty, L Archer, J Perry, J R W Govan, P A Corris, and K Gould Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation Thorax, June 1, 2004; 59(6): 526 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baldwin, P. A. Sokol, J. Parkhill, and E. Mahenthiralingam The Burkholderia cepacia Epidemic Strain Marker Is Part of a Novel Genomic Island Encoding Both Virulence and Metabolism-Associated Genes in Burkholderia cenocepacia Infect. Immun., March 1, 2004; 72(3): 1537 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomich and C. D. Mohr Transcriptional and Posttranscriptional Control of Cable Pilus Gene Expression in Burkholderia cenocepacia J. Bacteriol., February 15, 2004; 186(4): 1009 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Bernier, L. Silo-Suh, D. E. Woods, D. E. Ohman, and P. A. Sokol Comparative Analysis of Plant and Animal Models for Characterization of Burkholderia cepacia Virulence Infect. Immun., September 1, 2003; 71(9): 5306 - 5313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Detsika, J. E. Corkill, M. Magalhaes, K. J. Glendinning, C. A. Hart, and C. Winstanley Molecular Typing of, and Distribution of Genetic Markers among, Burkholderia cepacia Complex Isolates from Brazil J. Clin. Microbiol., September 1, 2003; 41(9): 4148 - 4153. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Sajjan, H. Xie, M. D. Lefebre, M. A. Valvano, and J. F. Forstner Identification and molecular analysis of cable pilus biosynthesis genes in Burkholderia cepacia Microbiology, April 1, 2003; 149(4): 961 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomich, A. Griffith, C. A. Herfst, J. L. Burns, and C. D. Mohr Attenuated Virulence of a Burkholderia cepacia Type III Secretion Mutant in a Murine Model of Infection Infect. Immun., March 1, 2003; 71(3): 1405 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Chung, E. Altman, T. J. Beveridge, and D. P. Speert Colonial Morphology of Burkholderia cepacia Complex Genomovar III: Implications in Exopolysaccharide Production, Pilus Expression, and Persistence in the Mouse Infect. Immun., February 1, 2003; 71(2): 904 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sajjan, L. Liu, A. Lu, T. Spilker, J. Forstner, and J. J. LiPuma Lack of cable pili expression by cblA-containing Burkholderia cepacia complex Microbiology, November 1, 2002; 148(11): 3477 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. CANT, S.B. GORDON, R.C. READ, C.A. HART, and C. WINSTANLEY Respiratory infections: Proceedings of the Eighth Liverpool Tropical School Bayer Symposium of Microbial Disease held on 3 February 2001 J. Med. Microbiol., November 1, 2002; 51(11): 903 - 914. [Full Text] [PDF] |
||||
![]() |
K. K. Chu, D. J. Davidson, T. K. Halsey, J. W. Chung, and D. P. Speert Differential Persistence among Genomovars of the Burkholderia cepacia Complex in a Murine Model of Pulmonary Infection Infect. Immun., May 1, 2002; 70(5): 2715 - 2720. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sajjan, G. Thanassoulis, V. Cherapanov, A. Lu, C. Sjolin, B. Steer, Y. J. Wu, O. D. Rotstein, G. Kent, C. McKerlie, et al. Enhanced Susceptibility to Pulmonary Infection with Burkholderia cepacia in Cftr{-}/{-} Mice Infect. Immun., August 1, 2001; 69(8): 5138 - 5150. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lutter, S. Lewenza, J. J. Dennis, M. B. Visser, and P. A. Sokol Distribution of Quorum-Sensing Genes in the Burkholderia cepacia Complex Infect. Immun., July 1, 2001; 69(7): 4661 - 4666. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. SAJJAN, M. COREY, A. HUMAR, E. TULLIS, E. CUTZ, C. ACKERLEY, and J. FORSTNER Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients J. Med. Microbiol., June 1, 2001; 50(6): 535 - 546. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |